此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Clinical Value of CT Perfusion in Peripheral Artery Disease (iPAD)

2026年9月8日 更新者:Zhijun Bao、Fudan University

Peripheral artery disease (PAD) affects millions worldwide and can lead to serious complications such as leg ulcers, gangrene, and amputation. Current imaging methods mainly evaluate large blood vessels but do not measure microcirculation in the foot. Computed tomography perfusion (CTP) is a new technique that can assess blood flow in small vessels.

The purpose of this study is to see whether combining CTP measurements with standard CT angiography images and patient clinical information can help predict which PAD patients are more likely to have poor outcomes after surgery to restore blood flow (revascularization). Poor outcomes include death or major limb problems such as amputation or need for another procedure.

This is an observational study. Researchers will collect data from about 200 adult PAD patients who are scheduled to undergo revascularization. Participants will receive routine care including CT scans before and after surgery. No experimental drugs or devices are given. Researchers will follow participants for up to 2 years after surgery through medical records and phone calls to track their recovery and any complications.

The results may help doctors identify high-risk patients earlier and improve treatment decisions.

研究概览

研究类型

观察性的

注册 (估计的)

200

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

  • 成人
  • 年长者

接受健康志愿者

不适用

取样方法

概率样本

研究人群

This study will enroll adult patients diagnosed with peripheral artery disease (PAD) who are scheduled to undergo vascular reconstruction (endovascular or surgical). Participants will receive CT perfusion imaging prior to the procedure. The study population aims to investigate the predictive value of CT perfusion parameters for postoperative adverse clinical events, with a planned follow-up period of 2 years.

描述

Inclusion Criteria:

  • Diagnosis of peripheral artery disease (PAD) confirmed by clinical evaluation and imaging (e.g., CTA, DSA).
  • Planned to undergo endovascular or surgical revascularization.
  • Age ≥ 18 years old.
  • Signed written informed consent.

Exclusion Criteria:

  • Allergy to iodinated contrast agents.
  • Severe renal insufficiency (e.g., eGFR < 30 mL/min/1.73m²).
  • Acute limb ischemia requiring emergency surgery.
  • Major limb amputation already performed prior to enrollment.
  • Life expectancy less than 2 years due to severe comorbidities.
  • Unwilling or unable to complete the 2-year follow-up.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Predictive value of CT perfusion for adverse clinical events after revascularization
大体时间:From baseline (preoperative) assessment through 2 years after revascularization
Assessment of the predictive value of computed tomography perfusion (CTP) parameters combined with CT angiography and clinical data for postoperative adverse outcomes. Adverse clinical events are defined as all-cause mortality, major adverse limb events (including major amputation and target limb reintervention), or non-healing ulcers/gangrene. Data will be collected through medical records and follow-up visits.
From baseline (preoperative) assessment through 2 years after revascularization

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年11月1日

初级完成 (估计的)

2029年9月30日

研究完成 (估计的)

2029年11月30日

研究注册日期

首次提交

2026年9月8日

首先提交符合 QC 标准的

2026年9月8日

首次发布 (实际的)

2026年9月14日

研究记录更新

最后更新发布 (实际的)

2026年9月14日

上次提交的符合 QC 标准的更新

2026年9月8日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅